CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-30 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −26,178 | $1.66 | $43K | 1,196,965 |
| 2018-12-29 | Lafond Kevin G SVP, Treasurer & CAO | Shares withheld for taxes | −17,667 | $1.66 | $29K | 70,867 |
| 2018-12-29 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −42,920 | $1.66 | $71K | 1,223,143 |
| 2018-12-29 | CANNON JAMES ANTHONY Director | Shares withheld for taxes | −4,315 | $1.66 | $7K | 383,050 |
| 2018-10-05 | KIRK RANDAL J Director | Other disposition · Series 1 Preferred Stock | −130,849 | 0 | ||
| 2018-09-28 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,295 | 130,849 | ||
| 2018-09-18 | Pagan Douglas W. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-18 | Ezickson Elan Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-18 | Braunstein Scott Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-08-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,282 | 129,554 | ||
| 2018-07-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,270 | 128,272 | ||
| 2018-06-29 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,257 | 127,002 | ||
| 2018-05-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,245 | 125,745 | ||
| 2018-05-05 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −123,333 | $4.41 | $544K | 1,266,063 |
| 2018-04-30 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,232 | 124,500 | ||
| 2018-04-25 | Hadfield Robert General Counsel and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-03-29 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,220 | 123,268 | ||
| 2018-02-28 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,208 | 122,048 | ||
| 2018-01-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,196 | 120,840 | ||
| 2017-12-31 | LEBEL FRANCOIS Executive Vice President R&D | Shares withheld for taxes | −21,667 | $4.14 | $90K | 200,566 |
Page 11 of 16 · 304 trades